The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Tumor microtubes convey resistance to surgical lesions and chemotherapy in gliomas
Open accessAbstract
BACKGROUND: Primary and adaptive resistance against chemo- and radiotherapy and local recurrence after surgery limit the benefits from these standard treatments in glioma patients. Recently we found that glioma cells can extend ultra-long membrane protrusions, "tumor microtubes" (TMs), for brain invasion, proliferation, and interconnection of single cells to a syncytium that is resistant to radiotherapy. We wondered whether TMs also convey resistance to the other 2 standard treatment modalities. METHODS: Patient-derived glioblastoma stemlike cell (GBMSC) lines were implanted under a cranial window in mice. Longitudinal in vivo two-photon laser scanning microscopy was used to follow tumor growth, including the fate of single glioma cells over months. RESULTS: After a cylindrical surgical lesion, GBMSCs increasingly extended TMs toward the lesion area, which contributed to the repopulation of this area over many weeks. In fact, an excessive "healing response" was observed in which tumor cell densities significantly exceeded those of unlesioned brain regions over time. Inhibition of TM formation and function by genetic targeting of growth associated protein-43 robustly suppressed this surgery-induced tumor growth reaction, in contrast to standard postsurgical anti-inflammatory treatment with dexamethasone. After one cycle of temozolomide chemotherapy, intra- and intertumoral heterogeneity of TM formation and interconnection was strongly associated with therapy response: when tumor cells were integrated in TM networks, they were more likely to resist chemotherapy. CONCLUSION: TMs can contribute to the resistance against standard treatment modalities in gliomas. Specific inhibition of TMs is a promising approach to reduce local recurrence after surgery and lower resistance to chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Stummer, W., Pichlmeier, U., Meinel, T., Wiestler, O. D., Zanella, F., & Reulen, H.-J. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70665-9 · Cited by 3,423
Inactivation of the DNA-Repair Gene MGMT and the Clinical Response of Gliomas to Alkylating Agents
Esteller, M., Garcia-Foncillas, J., Andion, E., Goodman, S. N., Hidalgo, O. F., Vanaclocha, V., Baylin, S. B., & Herman, J. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011093431901 · Cited by 2,224
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Johnson, B. E., Mazor, T., Hong, C., Barnes, M., Aihara, K., McLean, C. Y., Fouse, S. D., Yamamoto, S., Ueda, H., Tatsuno, K., et al. (2014) · Science · doi:10.1126/science.1239947 · Cited by 1,362
Westphal, M., Hilt, D. C., Bortey, E., Delavault, P., Olivares, R., Warnke, P. C., Whittle, I. R., Jääskeläinen, J., & Ram, Z. (2003) · Neuro-Oncology · doi:10.1093/neuonc/5.2.79 · Cited by 1,330
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Self-citationBrain tumour cells interconnect to a functional and resistant network
Osswald, M., Jung, E., Sahm, F., Solecki, G., Venkataramani, V., Blaes, J., Weil, S., Horstmann, H., Wiestler, B., Syed, M., et al. (2015) · Nature · doi:10.1038/nature16071 · Cited by 1,143
Self-citationReal-time imaging reveals the single steps of brain metastasis formation.
Kienast, Y., von Baumgarten, L., Fuhrmann, M., Klinkert, W. E. F., Goldbrunner, R., Herms, J., & Winkler, F. (2010) · Nature Medicine · doi:10.1038/nm.2072 · Cited by 1,138
Self-citationWick, W., Platten, M., Meisner, C., Felsberg, J., Tabatabai, G., Simon, M., Nikkhah, G., Papsdorf, K., Steinbach, J. P., Sabel, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70164-x · Cited by 1,135
Self-citationWeller, M., Wick, W., Aldape, K., Brada, M., Berger, M., Pfister, S. M., Nishikawa, R., Rosenthal, M., Wen, P. Y., Stupp, R., et al. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.17 · Cited by 1,124
Self-citationBrown, T. J., Brennan, M. C., Li, M., Church, E. W., Brandmeir, N. J., Rakszawski, K. L., Patel, A. S., Rizk, E. B., Suki, D., Sawaya, R., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.1373 · Cited by 1,081
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
Buckner, J. C., Shaw, E. G., Pugh, S. L., Chakravarti, A., Gilbert, M. R., Barger, G. R., Coons, S., Ricci, P., Bullard, D., Brown, P. D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1500925 · Cited by 1,064
Carcinoma–astrocyte gap junctions promote brain metastasis by cGAMP transfer
Chen, Q., Boire, A., Jin, X., Valiente, M., Er, E. E., Lopez-Soto, A., S. Jacob, L., Patwa, R., Shah, H., Xu, K., et al. (2016) · Nature · doi:10.1038/nature18268 · Cited by 969
Wick, W., Hartmann, C., Engel, C., Stoffels, M., Felsberg, J., Stockhammer, F., Sabel, M. C., Koeppen, S., Ketter, R., Meyermann, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.6497 · Cited by 809
Self-citationStandards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Self-citationMGMT testing—the challenges for biomarker-based glioma treatment
Wick, W., Weller, M., van den Bent, M., Sanson, M., Weiler, M., von Deimling, A., Plass, C., Hegi, M., Platten, M., & Reifenberger, G. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.100 · Cited by 579
Self-citationDevelopment of neuronal polarity: GAP-43 distinguishes axonal from dendritic growth cones
Goslin, K., Schreyer, D. J., Skene, J. H. P., & Banker, G. (1988) · Nature · doi:10.1038/336672a0 · Cited by 417
THE FORMS OF GROWTH IN GLIOMAS AND THEIR PRACTICAL SIGNIFICANCE
SCHERER, H. J. (1940) · Brain · doi:10.1093/brain/63.1.1 · Cited by 408
Petrecca, K., Guiot, M.-C., Panet-Raymond, V., & Souhami, L. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-012-0983-4 · Cited by 334
Intratumoral heterogeneity in glioblastoma: don't forget the peritumoral brain zone
Lemée, J.-M., Clavreul, A., & Menei, P. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov119 · Cited by 295
Winkler, F., Kienast, Y., Fuhrmann, M., Von Baumgarten, L., Burgold, S., Mitteregger, G., Kretzschmar, H., & Herms, J. (2009) · Glia · doi:10.1002/glia.20850 · Cited by 210
Self-citationLeu, S., von Felten, S., Frank, S., Vassella, E., Vajtai, I., Taylor, E., Schulz, M., Hutter, G., Hench, J., Schucht, P., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos317 · Cited by 192
Addressing Diffuse Glioma as a Systemic Brain Disease With Single-Cell Analysis
Capper, D. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.2910 · Cited by 188
Chowdhary, S. A., Ryken, T., & Newton, H. B. (2015) · Journal of Neuro-Oncology · doi:10.1007/s11060-015-1724-2 · Cited by 167
Astrocytes promote glioma invasion via the gap junction protein connexin43
Sin, W. C., Aftab, Q., Bechberger, J. F., Leung, J. H., Chen, H., & Naus, C. C. (2016) · Oncogene · doi:10.1038/onc.2015.210 · Cited by 163
Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide
Murphy, S. F., Varghese, R. T., Lamouille, S., Guo, S., Pridham, K. J., Kanabur, P., Osimani, A. M., Sharma, S., Jourdan, J., Rodgers, C. M., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1286 · Cited by 163
Munoz, J. L., Rodriguez‐Cruz, V., Greco, S. J., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.111 · Cited by 157
Okolie, O., Bagó, J. R., Schmid, R. S., Irvin, D., Bash, R., Miller, C. R., & Hingtgen, S. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now117 · Cited by 144
Opposing roles of connexin43 in glioma progression
Sin, W., Crespin, S., & Mesnil, M. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.10.022 · Cited by 139
Gielen, P. R., Aftab, Q., Ma, N., Chen, V. C., Hong, X., Lozinsky, S., Naus, C. C. G., & Sin, W. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.002 · Cited by 122
Differential Connexin Function Enhances Self-Renewal in Glioblastoma
Hitomi, M., Deleyrolle, L. P., Mulkearns-Hubert, E. E., Jarrar, A., Li, M., Sinyuk, M., Otvos, B., Brunet, S., Flavahan, W. A., Hubert, C. G., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.021 · Cited by 117
Chen, W.-L., Wang, D., Du, X., He, Y., Chen, S., Shao, Q., Ma, C., Huang, B., Chen, A., Zhao, P., et al. (2015) · Medical Oncology · doi:10.1007/s12032-015-0487-0 · Cited by 104
The brain tissue response to surgical injury and its possible contribution to glioma recurrence
Hamard, L., Ratel, D., Selek, L., Berger, F. R., van der Sanden, B. P. J., & Wion, D. (2016) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2096-y · Cited by 89
Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Lemke, D., Weiler, M., Blaes, J., Wiestler, B., Jestaedt, L., Klein, A., Löw, S., Eisele, G., Radlwimmer, B., Capper, D., et al. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12802 · Cited by 60
Self-citationINTRAGO: intraoperative radiotherapy in glioblastoma multiforme – a Phase I/II dose escalation study
Giordano, F. A., Brehmer, S., Abo‐Madyan, Y., Welzel, G., Sperk, E., Keller, A., Schneider, F. W., Clausen, S., Herskind, C., Schmiedek, P., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-992 · Cited by 57
Podoplanin: A Marker for Reactive Gliosis in Gliomas and Brain Injury
Kolar, K., Andrade, M. F., Bechberger, J. F., Krishnan, H., Goldberg, G. S., Naus, C. C. G., & Sin, W. C. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000150 · Cited by 53
Lin, Q., Liu, Z., Ling, F., & Xu, G. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4680 · Cited by 53
Steroid management in newly diagnosed glioblastoma
Deutsch, M. B., Panageas, K. S., Lassman, A. B., & DeAngelis, L. M. (2013) · Journal of Neuro-Oncology · doi:10.1007/s11060-013-1096-4 · Cited by 38
Licitra, L. F., Perrone, F., Tamborini, E., Bertola, L., Ghirelli, C., Negri, T., Orsenigo, M., Filipazzi, P., Pastore, E., Pompilio, M., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq756 · Cited by 34
Mannino, M., & Yarnold, J. R. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70040-3 · Cited by 20
Glioma resection and tumor recurrence: back to Semmelweis
Ratel, D., van der Sanden, B. P. J., & Wion, D. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now201 · Cited by 19
Ekblad, L., Lindgren, G., Persson, E., Kjellén, E., & Wennerberg, J. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-33 · Cited by 12
Cited by
Glutamatergic synaptic input to glioma cells drives brain tumour progression
Venkataramani, V., Tanev, D. I., Strahle, C., Studier-Fischer, A., Fankhauser, L., Kessler, T., Körber, C., Kardorff, M., Ratliff, M., Xie, R., et al. (2019) · Nature · doi:10.1038/s41586-019-1564-x · Cited by 1,197
Self-citationGlioblastoma hijacks neuronal mechanisms for brain invasion
Venkataramani, V., Yang, Y., Schubert, M. C., Reyhan, E., Tetzlaff, S. K., Wißmann, N., Botz, M., Soyka, S. J., Beretta, C. A., Pramatarov, R. L., et al. (2022) · Cell · doi:10.1016/j.cell.2022.06.054 · Cited by 632
Self-citationMultidimensional communication in the microenvirons of glioblastoma
Broekman, M. L., Maas, S. L. N., Abels, E. R., Mempel, T. R., Krichevsky, A. M., & Breakefield, X. O. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0025-8 · Cited by 579
Cancer neuroscience: State of the field, emerging directions
Winkler, F., Venkatesh, H. S., Amit, M., Batchelor, T., Demir, I. E., Deneen, B., Gutmann, D. H., Hervey-Jumper, S., Kuner, T., Mabbott, D., et al. (2023) · Cell · doi:10.1016/j.cell.2023.02.002 · Cited by 552
Self-citationGlioma synapses recruit mechanisms of adaptive plasticity
Taylor, K. R., Barron, T., Hui, A., Spitzer, A., Yalçin, B., Ivec, A. E., Geraghty, A. C., Hartmann, G. G., Arzt, M., Gillespie, S. M., et al. (2023) · Nature · doi:10.1038/s41586-023-06678-1 · Cited by 342
Metadata
- Authors
- Weil, S., Osswald, M., Solecki, G., Grosch, J., Jung, E., Lemke, D., Ratliff, M., Hänggi, D., Wick, W., & Winkler, F.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-04-17
- Volume
- 19
- Issue
- 10
- Pages
- 1316-1326
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2605795763
- Cited by
- 317
- References
- 43
- FWCI
- 11.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.